News and blog posts
15
Sep 2020
On September 03, 2020, the National Institute for Health and Care Excellence (NICE) issued medical technologies guidance on Axonics sacral neuromodulation (SNM) system for treating refractory overactive bladder. NICE recommended Axonics SNM to be adopted in the NHS and considered as an alternative when another treatment is not effective.
Read more
14
Sep 2020
On August 18, 2020, Swedish Medical Technology Product (MTP) Council issued an updated recommendation on FreeStyle Libre for continuous glucose monitoring in diabetes, which now includes FreeStyle Libre 2. The previous recommendation was published by New Therapy (NT) Council in 2018.
Read more
14
Sep 2020
The first issue of HTA Alerts included 186 reports from European organizations only. This issue included reports, published or initiated from the 1st of August 2020, and ongoing reports. The most common technological fields were cardiovascular, gastroenterology, in-vitro diagnostics, men's health, neuromodulation, and orthopedics. Contact us if you want to receive a sample alert and to learn more about the service.
Read more
11
Sep 2020
The French National Authority for Health (HAS) released new decisions about intra-DRG reimbursement of medical devices from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in July 2020. Decisions concern cardiac sutureless valve bioprostheses and implantable devices for the treatment of urinary incontinence.
Read more
10
Sep 2020
From October 1, 2020, balneophototherapy can also be used for patients with moderate to severe neurodermatitis and billed via the EBM (German Uniform Evaluation Standard). So far, dermatologists have only been able to use the method for patients with psoriasis.
Read more
09
Sep 2020
At the end of July 2020, the network of European HTA agencies, EUnetHTA, announced the final plan of the project OTCA27 “Comparative effectiveness of surgical techniques and devices for the treatment of benign prostatic hyperplasia (BPH).”
Read more
08
Sep 2020
The NHS Innovation Accelerator (NIA) has launched its call for applications representing high impact, evidence-based innovations from September 01, 2020. The application deadline is October 16, 2020. NIA is an award-winning national initiative supported by England’s 15 Academic Health Science Networks (AHSNs), which helps dedicated innovations to spread more comprehensively in the healthcare system.
Read more
07
Sep 2020
The French National Authority for Health (HAS) released new decisions about add-on and medical aid reimbursement of many medical devices from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in August 2020. Decisions concern cartilage implant, energy return prosthetic feet, and Yttrium-90 microspheres.
Read more
04
Sep 2020
The Ministry of Health has adjusted the regulatory nomenclature of medical devices, separating software, which is a medical device, into a separate group. The classification of software is given depending on the potential risk of its use. A potential risk class is assigned to software regardless of the potential risk class of the medical device in combination with which it is used. The order does not apply to medical products previously submitted for state registration.
Read more
03
Sep 2020
On behalf of the Federal Joint Committee (G-BA), the Institute for Quality and Efficiency in Health Care (IQWiG) investigated to what extent adults with symptomatic knee cartilage defect (but without advanced arthrosis) could benefit from autologous chondrocyte implantation (ACI) of different types: periosteal-covered (ACI-P), collagen-covered (ACI-C) or matrix-associated (M-ACI).
Read more
02
Sep 2020
In July 2020, the Austrian Institute for Health Technology Assessment (AIHTA) issued an updated report on the PET/PET-CT evidence for need-based planning in Austria.
Read more
01
Sep 2020
In July 2020, the National Institute for Health and Care Excellence (NICE) published two new interventional procedure guidance (for artificial iris insertion for acquired aniridia and for congenital aniridia), and two Medtech innovation briefings (for Prontosan for acute and chronic wounds, and CFHealthHub for managing cystic fibrosis during the COVID-19 pandemic).
Read more